[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Center of Demielisation Diseases 'Neuroclinic', Moscow, Russia., Lashch NY; Pirogov Russian National Research Medical University, City Clinical Hospital #24, Moscow, Russia., Sharanova SN; City Clinical Hospital #24, Moscow, Russia., Zakharova MN; Neurology Research Center, Moscow, Russia., Trifonova OV; Neurology Research Center, Moscow, Russia., Simaniv TO; Neurology Research Center, Moscow, Russia., Lysogorskaya EV; Neurology Research Center, Moscow, Russia., Guryanova OE; Neurology Research Center, Moscow, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Iakushina TI; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Lizhdvoy VY; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Belova YA; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Khabirov FA; Republican Clinical and Diagnostic Center of Demielisation Diseases, Kazan, Russia., Babicheva NN; Republican Clinical and Diagnostic Center of Demielisation Diseases, Kazan, Russia., Khaibullin TI; Republican Clinical and Diagnostic Center of Demielisation Diseases, Kazan, Russia., Granatov EV; Republican Clinical and Diagnostic Center of Demielisation Diseases, Kazan, Russia., Averyanova LA; Republican Clinical and Diagnostic Center of Demielisation Diseases, Kazan, Russia., Sazonov DV; Unit of Clinical Researches of Multiple Sclerosis of 'Siberian Regional Center', Novosibirsk, Russia., Odinak MM; Kirov Military Medical Academy, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Hospital, Rostov-on-Don, Russia., Tsukurova LA; Ochapovsky Regional Clinical Hospital #1, Krasnodar, Russia., Sergeeva AI; Ochapovsky Regional Clinical Hospital #1, Krasnodar, Russia., Ivanov RA; JSC BIOCAD, St. Petersburg, Russia., Shustova MS; JSC BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2016; Vol. 116 (10 Pt 2), pp. 61-67.

[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results)].

Autor: Iakushina TI, Lizhdvoĭ VIu, Vasilenko IA, Andriukhina OM, Kotov SV

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2013; Vol. 113 (2 Pt 2), pp. 61-5.

[Rare case of no effective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug].

Autor: Iakushina TI, Eliseev IuV, Kotov SV

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2013; Vol. 113 (2 Pt 2), pp. 83-6.

[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region].

Autor: Kotov SV, Iakushina TI, Lizhdvoĭ VIu

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2012; Vol. 112 (3 Pt 1), pp. 60-2.